EcoDrugPlus

Ensembl ID : ENSEEEG00000024012
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSEEEG00000005549
Gene Symbol: -
Cross references: -
628 Possible Orthologues:

Ensembl ID : ENSEEEG00000011988
Gene Symbol: -
Cross references: -
616 Possible Orthologues:

Ensembl ID : ENSEEEG00000011990
Gene Symbol: -
Cross references: -
614 Possible Orthologues:

Ensembl ID : ENSEEEG00000011991
Gene Symbol: -
Cross references: -
616 Possible Orthologues:

Ensembl ID : ENSEEEG00000011992
Gene Symbol: -
1 Cross references
628 Possible Orthologues:

Ensembl ID : ENSEEEG00000011995
Gene Symbol: -
Cross references: -
628 Possible Orthologues:

Ensembl ID : ENSEEEG00000005551
Gene Symbol: -
1 Cross references
628 Possible Orthologues:

Ensembl ID : ENSEEEG00000023222
Gene Symbol: -
1 Cross references
196 Possible Orthologues:

Ensembl ID : ENSEEEG00000012922
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSEEEG00000006300
Gene Symbol: -
1 Cross references
194 Possible Orthologues:

Ensembl ID : ENSEEEG00000006660
Gene Symbol: -
Cross references: -
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).